INVEGA SUSTENNA 156 mg/mL
paliperidone palmitate · INJECTION · Janssen Pharmaceuticals, Inc.
INVEGA SUSTENNA is a injection containing paliperidone palmitate at 156 mg/mL, taken intramuscular. Manufactured by Janssen Pharmaceuticals, Inc..
Key Facts
- Brand Name
- INVEGA SUSTENNA
- Generic Name
- paliperidone palmitate
- NDC Code (Product)
50458-563- Manufacturer
- Janssen Pharmaceuticals, Inc.
- Strength
- 156 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- NDA022264
- Marketing Start
- 07/31/2009
Recall History
Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Frequently Asked Questions
What is INVEGA SUSTENNA used for?
INVEGA SUSTENNA contains paliperidone palmitate. It is a injection taken intramuscular. Consult your doctor for specific uses.
Is INVEGA SUSTENNA a controlled substance?
INVEGA SUSTENNA is not classified as a controlled substance by the DEA.
What is the generic name for INVEGA SUSTENNA?
The generic name for INVEGA SUSTENNA is paliperidone palmitate. There are 8 other brand versions of paliperidone palmitate.
What is the NDC code for INVEGA SUSTENNA 156 mg/mL?
The NDC (National Drug Code) for INVEGA SUSTENNA 156 mg/mL is 50458-563, listed by Janssen Pharmaceuticals, Inc..
Other INVEGA SUSTENNA Dosages
Other Paliperidone Brands
See all →- INVEGA TRINZA273 mg/.88mL50458-606
- Erzofri extended-release78 mg/.5mL72526-106
- INVEGA TRINZA819 mg/2.63mL50458-609
- INVEGA TRINZA410 mg/1.32mL50458-607
- INVEGA HAFYERA1092 mg/3.5mL50458-611
- Erzofri extended-release156 mg/mL72526-108
- INVEGA TRINZA546 mg/1.75mL50458-608
- Erzofri extended-release234 mg/1.5mL72526-109
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)